Bessemer Group Inc. Acquires 70,461 Shares of Transcat, Inc. (NASDAQ:TRNS)

Bessemer Group Inc. boosted its holdings in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 64.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 180,069 shares of the scientific and technical instruments company's stock after acquiring an additional 70,461 shares during the quarter. Bessemer Group Inc. owned about 1.93% of Transcat worth $13,404,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of TRNS. Jones Financial Companies Lllp grew its stake in shares of Transcat by 686.7% in the 4th quarter. Jones Financial Companies Lllp now owns 354 shares of the scientific and technical instruments company's stock worth $37,000 after purchasing an additional 309 shares during the last quarter. Aquatic Capital Management LLC boosted its holdings in Transcat by 1,052.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,152 shares of the scientific and technical instruments company's stock worth $122,000 after buying an additional 1,052 shares in the last quarter. GAMMA Investing LLC boosted its holdings in Transcat by 10,137.5% during the first quarter. GAMMA Investing LLC now owns 1,638 shares of the scientific and technical instruments company's stock worth $122,000 after buying an additional 1,622 shares in the last quarter. Morgan Dempsey Capital Management LLC acquired a new position in Transcat in the fourth quarter worth approximately $143,000. Finally, KLP Kapitalforvaltning AS bought a new position in shares of Transcat in the fourth quarter valued at $190,000. 98.34% of the stock is owned by institutional investors and hedge funds.

Transcat Trading Up 1.3%

Shares of Transcat stock traded up $1.14 during trading on Monday, hitting $85.96. The stock had a trading volume of 118,855 shares, compared to its average volume of 89,798. Transcat, Inc. has a 1 year low of $67.56 and a 1 year high of $147.12. The stock has a 50 day simple moving average of $82.63 and a 200 day simple moving average of $85.18. The company has a quick ratio of 1.87, a current ratio of 2.29 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $801.15 million, a PE ratio of 55.10 and a beta of 0.75.

Transcat (NASDAQ:TRNS - Get Free Report) last posted its quarterly earnings data on Monday, May 19th. The scientific and technical instruments company reported $0.64 EPS for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). The firm had revenue of $77.13 million during the quarter, compared to analyst estimates of $76.40 million. Transcat had a return on equity of 6.47% and a net margin of 5.21%. The firm's revenue for the quarter was up 8.8% on a year-over-year basis. On average, research analysts expect that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Analysts Set New Price Targets

TRNS has been the subject of several research reports. Wall Street Zen raised Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday, May 28th. HC Wainwright reaffirmed a "buy" rating and set a $116.00 target price on shares of Transcat in a report on Wednesday, June 25th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $114.00.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.